134 related articles for article (PubMed ID: 20546434)
1. Outcomes of HCV treatment: who does well and who does not?
Hsu CS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):846-8. PubMed ID: 20546434
[No Abstract] [Full Text] [Related]
2. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response to chronic hepatitis C treatment.
Moraes Coelho HS; Villela-Nogueira CA
Ann Hepatol; 2010; 9 Suppl():54-60. PubMed ID: 20713997
[TBL] [Abstract][Full Text] [Related]
5. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.
Villa E; Karampatou A; Cammà C; Di Leo A; Luongo M; Ferrari A; Petta S; Losi L; Taliani G; Trande P; Lei B; Graziosi A; Bernabucci V; Critelli R; Pazienza P; Rendina M; Antonelli A; Francavilla A
Gastroenterology; 2011 Mar; 140(3):818-29. PubMed ID: 21167831
[TBL] [Abstract][Full Text] [Related]
6. The APRI and the RVR.
Snyder N; Petersen JR
J Clin Gastroenterol; 2009; 43(5):500-1. PubMed ID: 19098684
[No Abstract] [Full Text] [Related]
7. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
8. Review article: predicting response in hepatitis C virus therapy.
Mihm U; Herrmann E; Sarrazin C; Zeuzem S
Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
[TBL] [Abstract][Full Text] [Related]
9. Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
Manolakopoulos S; Deutsch MJ; Anagnostou O; Karatapanis S; Tiniakou E; Papatheodoridis GV; Georgiou E; Manesis E; Tzourmakliotis D; Archimandritis AJ
Liver Int; 2010 Nov; 30(10):1454-60. PubMed ID: 20846344
[TBL] [Abstract][Full Text] [Related]
10. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis C and liver transplantation].
Durand F
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312
[No Abstract] [Full Text] [Related]
12. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
Serfaty L
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B202-5. PubMed ID: 12180289
[No Abstract] [Full Text] [Related]
13. Insulin resistance, hepatitis C, and liver transplantation.
Alsatie M; Pandya P; Chalasani NP
Liver Transpl; 2008 Feb; 14(2):136-7. PubMed ID: 18236446
[No Abstract] [Full Text] [Related]
14. [Evaluation of response to treatment in chronic hepatitis C].
Leroy V; Hilleret MN
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B23-31. PubMed ID: 12180294
[No Abstract] [Full Text] [Related]
15. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
16. An economic analysis of antiviral therapy in patients with advanced hepatitis C virus disease: still not there!
Rubin A; Berenguer M
Liver Transpl; 2010 Jun; 16(6):697-700. PubMed ID: 20517902
[No Abstract] [Full Text] [Related]
17. [Treatment of naive patients with chronic hepatitis C].
Vince A; Duvnjak M
Acta Med Croatica; 2009 Dec; 63(5):409-15. PubMed ID: 20198900
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of chronic hepatitis C and alcohol consumption].
Mathurin P; Canva V; Dharancy S; Paris JC
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B248-51. PubMed ID: 12180297
[No Abstract] [Full Text] [Related]
19. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
Bressler BL; Guindi M; Tomlinson G; Heathcote J
Hepatology; 2003 Sep; 38(3):639-44. PubMed ID: 12939590
[TBL] [Abstract][Full Text] [Related]
20. Further insights into the causes of thrombocytopenia in chronic hepatitis C.
Giannini EG; Savarino V
J Gastrointestin Liver Dis; 2010 Dec; 19(4):357-8. PubMed ID: 21188322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
